Gentry Leesa
SEC insider (Form 3/4/5 filer). CIK 0002013097. Chief Clinical Officer at RenovoRx, Inc. (RNXT). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 3, 2026. Located in MOUNTAIN VIEW, CA.
Companies Gentry Leesa has filed insider reports for
- RenovoRx, Inc. (RNXT): Officer, Chief Clinical Officer
Gentry Leesa
CIK: 0002013097
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNXT
RenovoRx, Inc.
Officer